NCT02466152View on ClinicalTrials.gov

Pharmacokinetic Study of Topical GSK2894512 Cream

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

May 28, 2015

Primary Completion Date

October 27, 2015

Study Completion Date

October 27, 2015

Conditions
Dermatitis, Atopic
Interventions
DRUG

GSK2894512 Topical Cream

GSK2894512 will be supplied as white to off-white topical cream in doses of 2.0% (20 milligrams/gram \[mg/g\]) and 1.0% (10 mg/g)

Trial Locations (1)

H2K 4L5

GSK Investigational Site, Montreal

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT02466152 - Pharmacokinetic Study of Topical GSK2894512 Cream | Biotech Hunter | Biotech Hunter